» Articles » PMID: 20463813

Phylodynamic Reconstruction Reveals Norovirus GII.4 Epidemic Expansions and Their Molecular Determinants

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2010 May 14
PMID 20463813
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

Noroviruses are the most common cause of viral gastroenteritis. An increase in the number of globally reported norovirus outbreaks was seen the past decade, especially for outbreaks caused by successive genogroup II genotype 4 (GII.4) variants. Whether this observed increase was due to an upswing in the number of infections, or to a surveillance artifact caused by heightened awareness and concomitant improved reporting, remained unclear. Therefore, we set out to study the population structure and changes thereof of GII.4 strains detected through systematic outbreak surveillance since the early 1990s. We collected 1383 partial polymerase and 194 full capsid GII.4 sequences. A Bayesian MCMC coalescent analysis revealed an increase in the number of GII.4 infections during the last decade. The GII.4 strains included in our analyses evolved at a rate of 4.3-9.0x10(-3) mutations per site per year, and share a most recent common ancestor in the early 1980s. Determinants of adaptation in the capsid protein were studied using different maximum likelihood approaches to identify sites subject to diversifying or directional selection and sites that co-evolved. While a number of the computationally determined adaptively evolving sites were on the surface of the capsid and possible subject to immune selection, we also detected sites that were subject to constrained or compensatory evolution due to secondary RNA structures, relevant in virus-replication. We highlight codons that may prove useful in identifying emerging novel variants, and, using these, indicate that the novel 2008 variant is more likely to cause a future epidemic than the 2007 variant. While norovirus infections are generally mild and self-limiting, more severe outcomes of infection frequently occur in elderly and immunocompromized people, and no treatment is available. The observed pattern of continually emerging novel variants of GII.4, causing elevated numbers of infections, is therefore a cause for concern.

Citing Articles

Measures for preventing norovirus outbreaks on campus in economically underdeveloped areas and countries: evidence from rural areas in Western China.

Xiong H, Ma F, Tang D, Liu D Front Public Health. 2024; 12:1406133.

PMID: 38894991 PMC: 11183813. DOI: 10.3389/fpubh.2024.1406133.


Antigenic Characterization of Novel Human Norovirus GII.4 Variants San Francisco 2017 and Hong Kong 2019.

Tohma K, Landivar M, Ford-Siltz L, Pilewski K, Kendra J, Niendorf S Emerg Infect Dis. 2024; 30(5):1026-1029.

PMID: 38666659 PMC: 11060466. DOI: 10.3201/eid3005.231694.


Global and regional circulation trends of norovirus genotypes and recombinants, 1995-2019: A comprehensive review of sequences from public databases.

Kendra J, Tohma K, Parra G Rev Med Virol. 2022; 32(5):e2354.

PMID: 35481689 PMC: 9542180. DOI: 10.1002/rmv.2354.


Benchmarking different approaches for Norovirus genome assembly in metagenome samples.

Fuentes-Trillo A, Monzo C, Manzano I, Santiso-Bellon C, de Andrade J, Gozalbo-Rovira R BMC Genomics. 2021; 22(1):849.

PMID: 34819031 PMC: 8611953. DOI: 10.1186/s12864-021-08067-2.


Identification of Human Norovirus GII.3 Blockade Antibody Epitopes.

Yi Y, Wang S, Wang X, Xiong P, Liu Q, Zhang C Viruses. 2021; 13(10).

PMID: 34696487 PMC: 8539815. DOI: 10.3390/v13102058.


References
1.
Parrino T, Schreiber D, Trier J, Kapikian A, Blacklow N . Clinical immunity in acute gastroenteritis caused by Norwalk agent. N Engl J Med. 1977; 297(2):86-9. DOI: 10.1056/NEJM197707142970204. View

2.
Bok K, Abente E, Realpe-Quintero M, Mitra T, Sosnovtsev S, Kapikian A . Evolutionary dynamics of GII.4 noroviruses over a 34-year period. J Virol. 2009; 83(22):11890-901. PMC: 2772697. DOI: 10.1128/JVI.00864-09. View

3.
Vinje J, Hamidjaja R, Sobsey M . Development and application of a capsid VP1 (region D) based reverse transcription PCR assay for genotyping of genogroup I and II noroviruses. J Virol Methods. 2004; 116(2):109-17. DOI: 10.1016/j.jviromet.2003.11.001. View

4.
Drummond A, Ho S, Phillips M, Rambaut A . Relaxed phylogenetics and dating with confidence. PLoS Biol. 2006; 4(5):e88. PMC: 1395354. DOI: 10.1371/journal.pbio.0040088. View

5.
Tu E, Bull R, Kim M, McIver C, Heron L, Rawlinson W . Norovirus excretion in an aged-care setting. J Clin Microbiol. 2008; 46(6):2119-21. PMC: 2446857. DOI: 10.1128/JCM.02198-07. View